Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Aspira Pathlab and Diagnostics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Aspira Pathlab and Diagnostics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aspira Pathlab & Dia posts Q3 net loss of Rs 1.56 cr

    10 Feb 2026, 7:50PM The company reported standalone net loss during the quarter stood at Rs 1.56 crore compared to net profit of Rs 0.38 crore in the previous year quarte
  • Aspira Pathlab & Dia - Unaudited Standalone Financial Results & Limited Review Report For Quarter Ended December 31, 2025

    10 Feb 2026, 7:26PM Q3/2025-26 Financial Results
  • Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of The Board Meeting For The Approval Of Unaudited Standalone Financ

    10 Feb 2026, 7:06PM Approval of the Unaudited Standalone Financial Results for third quarter and nine months ended on December 31, 2025
  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate

    6 Feb 2026, 8:42PM Outcome of Postal Ballot
  • Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    6 Feb 2026, 7:18PM Voting Results & Scrutinizer Report of Postal Ballot conducted by remote e-voting process.
  • Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results Alongwith Limited Revi

    4 Feb 2026, 8:55PM Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to
  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    16 Jan 2026, 7:00PM As of December 2025, 18.39% is owned by Indian Promoters and 81.61% by Public. <p align=justify> Top four Promoters holding highest number of shares o
  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 5:04PM Compliance Certificate under reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025
  • Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    6 Jan 2026, 5:09PM Intimation of Postal Ballot Notice for appointment of Mrs. Kiran Awasthi (DIN:09066721) as an Independent Director for the first term of 5 consecutive
  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Demise

    5 Jan 2026, 7:02PM Revised disclosure pertaining to the demise of Dr. Alaka Keshav Deshapande ,pursuant to the observation email received from BSE
  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Demise

    2 Jan 2026, 8:57PM Demise of Independent Director - Dr. Alaka Keshav Deshpande (DIN:11238406)

Key fundamentals

Evaluate the intrinsic value of Aspira Pathlab and Diagnostics Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 13.4227 11.2205 13.7122 13.6482 9.5651
Liabilities 13.4227 11.2205 13.7122 13.6482 9.5651
Equity 10.293 10.293 10.293 10.293 10.293
Gross Profit 3.5249 -1.1868 1.5932 6.3731 3.5132
Net Profit 2.0726 -2.6722 -0.0887 4.4594 1.381
Cash From Operating Activities 1.877 1.053 -0.0121 2.031 5.6734
NPM(%) 9.42 -20.23 -0.61 22.81 9.08
Revenue 21.999 13.2049 14.4569 19.5419 15.2054
Expenses 18.4741 14.3917 12.8637 13.1688 11.6922
ROE(%) 28.64 -36.92 -1.22 61.62 19.08

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aspira Pathlab and Diagnostics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 738.00 0.42 43.60 34.82 301.39 0.68
Lotus Eye Hospital and Institute Ltd 123.80 4.65 400.00 126.88 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 18.53 0.27 0.00 263.44 -39.50 0.00
Astec Lifesciences Ltd 640.15 2.97 0.00 119.65 -604.77 0.00

Company Info

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016. 2025-The Company Acquire 100% of stake in Aspira DNA Diagnostics Gujarat LLP.

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016. 2025-The Company Acquire 100% of stake in Aspira DNA Diagnostics Gujarat LLP.

Read More

Parent Organisation

Aspira Pathlab & Diagnostics Ltd.

Founded

03/07/1973

Managing Director

Dr.Pankaj J Shah

NSE Symbol

FAQ

The current price of Aspira Pathlab and Diagnostics Ltd is

The 52-week high for Aspira Pathlab and Diagnostics Ltd is

The market capitalization of Aspira Pathlab and Diagnostics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aspira Pathlab and Diagnostics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aspira Pathlab and Diagnostics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aspira Pathlab and Diagnostics Ltd shares.

The CEO of Aspira Pathlab and Diagnostics Ltd is Dr.Pankaj J Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT